The principal component of blood clots is a protein meshwork called fi
brin. The precursor protein, fibrinogen, occurs in a soluble form in t
he blood plasma where it is activated by thrombin when and if the need
arises. More than a century after first being purified, fibrinogen ha
s yet to have its detailed 3-dimensional structure revealed. The situa
tion is changing rapidly, however, and crystallographic studies in pro
gress in several laboratories on a variety of fragments and complexes
may soon reveal not only its structure but also the subtleties of how
this large glycoprotein is transformed into a fibrin clot.